Skip to main content
Caplight Logo









Cellaven

Cellaven

Private
FranceHealthcare & Life Scienceshttps://cellaven.com/

Last Round

Seed

Jul 3, 2024

Total Funding Raised

$3.04M

Company Overview

Cellaven is a laboratory equipment company that manufactures an automated cell culture device intended to improve the efficiency and reproducibility of cell culture research.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

automated cell culturecell culture automationliquid handling robotlab automationbenchtop automationbiotech equipmentlab roboticsautomated cell passagingorganoid culture automationstem cell culturelife science automationR&D laboratory equipmentcapital equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellaven Comparables

Compare Cellaven with similar companies based on industry and business-model similarity.

Cellaven comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
mo:re
82%
Cell X Technologies
73%
FORMULATRIX
73%

Cellaven Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 3, 2024

Key People

Founding team and executive leadership

Marc Barsoum

Chief Revenue Officer (CRO) & Co-Founder

Founding Team

Julien Maruotti

Co-founder & CEO

Founding Team

Cellaven Investors

Notable investors and investment history

Cellaven investors
InvestorRounds
Finovam GestionSeed
BpifranceSeed
INSEAD AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 3, 2024

    $3M round led by Bpifrance and Finovam

Cellaven Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellaven Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellaven's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Employee Range7
Year Founded2022
Last FundingJul 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?